By News on the Net -- Catholic Vote——Bio and Archives--December 5, 2023
| CFP Comments | Subscribe | Email Us
The Food and Drug Administration (FDA) is reportedly interested in conducting a study of so-called “gender-affirming” drugs on minors, potentially with participants as young as 13.
According to POLITICO, the
Research Institute for Gender Therapeutics (RIGT) “said the FDA had
provided feedback on its proposal for a late-stage clinical trial
studying the use of estradiol, a form of the hormone estrogen.” RIGT is a
nonprofit that supports “transitioning” minors. ---More...
View Comments
News from around the world